AT&T Inc. (BIT:1T)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	174,441	157,810	108,543	122,757	154,465	167,519
Market Cap Growth	38.66%	45.39%	-11.58%	-20.53%	-7.79%	-34.15%
Enterprise Value	311,150	313,576	263,335	287,135	335,366	328,854
Last Close Price	24.41	21.39	13.95	14.87	13.39	13.30
PE Ratio	16.18	15.20	8.45	-	8.84	-
PS Ratio	1.65	1.34	0.98	1.09	1.31	1.43
PB Ratio	1.66	1.36	1.00	1.23	0.96	1.14
P/FCF Ratio	-	8.83	5.86	10.58	6.65	7.21
P/OCF Ratio	-	4.21	3.13	4.10	4.19	4.75
EV/Sales Ratio	2.93	2.65	2.38	2.54	2.85	2.81
EV/EBITDA Ratio	6.76	7.39	6.94	7.07	7.67	9.22
EV/EBIT Ratio	12.09	12.27	11.12	10.83	10.97	16.47
EV/FCF Ratio	18.62	17.54	14.23	24.75	14.44	14.15
Debt / Equity Ratio	1.23	1.21	1.33	1.49	1.08	1.02
Debt / EBITDA Ratio	3.01	2.92	3.35	3.24	3.62	3.74
Debt / FCF Ratio	7.75	7.84	7.79	12.76	7.54	6.43
Asset Turnover	0.31	0.31	0.30	0.25	0.25	0.27
Inventory Turnover	23.97	22.14	18.91	15.77	17.21	20.02
Quick Ratio	0.51	0.40	0.43	0.35	0.34	0.53
Current Ratio	0.81	0.67	0.71	0.59	1.61	0.82
Return on Equity (ROE)	11.53%	10.23%	13.83%	-4.74%	13.10%	-0.80%
Return on Assets (ROA)	4.17%	4.12%	4.04%	3.71%	4.03%	2.83%
Return on Capital (ROIC)	6.13%	6.08%	6.02%	5.47%	5.83%	4.06%
Return on Capital Employed (ROCE)	7.50%	7.60%	7.40%	8.20%	7.80%	5.30%
Earnings Yield	6.18%	6.70%	12.00%	-6.50%	11.43%	-2.53%
FCF Yield	9.58%	11.33%	17.05%	9.45%	15.04%	13.88%
Dividend Yield	3.09%	5.01%	7.20%	6.99%	13.66%	12.78%
Payout Ratio	64.36%	74.97%	56.50%	-	75.04%	-
Buyback Yield / Dilution	-0.35%	0.74%	-1.28%	4.49%	-4.83%	2.60%
Total Shareholder Return	2.74%	5.76%	5.91%	11.48%	8.83%	15.38%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.